Clonal distribution of disease-associated and healthy carrier isolates of Neisseria meningitidis between 1983 and 2005 in Cuba
- PMID: 20042619
- PMCID: PMC2832447
- DOI: 10.1128/JCM.01653-09
Clonal distribution of disease-associated and healthy carrier isolates of Neisseria meningitidis between 1983 and 2005 in Cuba
Abstract
In response to epidemic levels of serogroup B meningococcal disease in Cuba during the 1980s, the VA-MENGOC-BC vaccine was developed and introduced into the National Infant Immunization Program in 1991. Since then the incidence of meningococcal disease in Cuba has returned to the low levels recorded before the epidemic. A total of 420 Neisseria meningitidis strains collected between 1983 and 2005 in Cuba were analyzed by multilocus sequence typing (MLST). The set of strains comprised 167 isolated from disease cases and 253 obtained from healthy carriers. By MLST analysis, 63 sequence types (STs) were identified, and 32 of these were reported to be a new ST. The Cuban isolates were associated with 12 clonal complexes; and the most common were ST-32 (246 isolates), ST-53 (86 isolates), and ST-41/44 (36 isolates). This study also showed that the application of VA-MENGOC-BC, the Cuban serogroup B and C vaccine, reduced the frequency and diversity of hypervirulent clonal complexes ST-32 (vaccine serogroup B type-strain) and ST-41/44 and also affected other lineages. Lineages ST-8 and ST-11 were no longer found during the postvaccination period. The vaccine also affected the genetic composition of the carrier-associated meningococcal isolates. The number of carrier isolates belonging to hypervirulent lineages decreased significantly after vaccination, and ST-53, a sequence type common in carriers, became the predominant ST.
Figures


Similar articles
-
The genetic structure of Neisseria meningitidis populations in Cuba before and after the introduction of a serogroup BC vaccine.Infect Genet Evol. 2010 May;10(4):546-54. doi: 10.1016/j.meegid.2010.02.002. Epub 2010 Feb 13. Infect Genet Evol. 2010. PMID: 20156598
-
Prevalence and epidemiology of meningococcal carriage in Southern Ethiopia prior to implementation of MenAfriVac, a conjugate vaccine.BMC Infect Dis. 2016 Nov 4;16(1):639. doi: 10.1186/s12879-016-1975-3. BMC Infect Dis. 2016. PMID: 27814682 Free PMC article.
-
Evaluation of Neisseria meningitidis Carriage with the Analysis of Serogroups, Genogroups and Clonal Complexes among Polish Soldiers.Pol J Microbiol. 2018;67(4):493-500. doi: 10.21307/pjm-2018-058. Pol J Microbiol. 2018. PMID: 30550236 Free PMC article.
-
Neisseria meningitidis; clones, carriage, and disease.Clin Microbiol Infect. 2014 May;20(5):391-5. doi: 10.1111/1469-0691.12647. Clin Microbiol Infect. 2014. PMID: 24766477 Review.
-
Meningococcal carriage and disease--population biology and evolution.Vaccine. 2009 Jun 24;27 Suppl 2(4):B64-70. doi: 10.1016/j.vaccine.2009.04.061. Epub 2009 May 21. Vaccine. 2009. PMID: 19464092 Free PMC article. Review.
Cited by
-
Carriage of Neisseria Meningitidis in Low and Middle Income Countries of the Americas and Asia: A Review of the Literature.Infect Dis Ther. 2020 Jun;9(2):209-240. doi: 10.1007/s40121-020-00291-9. Epub 2020 Apr 2. Infect Dis Ther. 2020. PMID: 32242281 Free PMC article. Review.
-
Survival of Neisseria meningitidis outside of the host: environmental effects and differences among strains.Epidemiol Infect. 2017 Dec;145(16):3525-3534. doi: 10.1017/S0950268817002473. Epub 2017 Nov 6. Epidemiol Infect. 2017. PMID: 29103405 Free PMC article.
-
Cross-protection induced by VA-MENGOC-BC® vaccine.Hum Vaccin Immunother. 2018 May 4;14(5):1064-1068. doi: 10.1080/21645515.2018.1438028. Epub 2018 Feb 26. Hum Vaccin Immunother. 2018. PMID: 29420119 Free PMC article.
-
First Use of a Serogroup B Meningococcal Vaccine in the US in Response to a University Outbreak.Pediatrics. 2015 May;135(5):798-804. doi: 10.1542/peds.2014-4015. Pediatrics. 2015. PMID: 25917990 Free PMC article.
-
Broad vaccine protection against Neisseria meningitidis using factor H binding protein.Vaccine. 2020 Nov 17;38(49):7716-7727. doi: 10.1016/j.vaccine.2020.08.031. Epub 2020 Aug 30. Vaccine. 2020. PMID: 32878710 Free PMC article. Review.
References
-
- Abdillahi, H., and J. T. Poolman. 1988. Definition of meningococcal class 1 OMP subtyping antigens by monoclonal antibodies. FEMS Microbiol. Immunol. 1:139-144. - PubMed
-
- Abdillahi, H., and J. T. Poolman. 1988. Typing of group-B Neisseria meningitidis with monoclonal antibodies in the whole-cell ELISA. J. Med. Microbiol. 26:177-180. - PubMed
-
- Baethgen, L. F., L. Weidlich, C. Moraes, C. Klein, L. S. Nunes, P. I. Cafrune, A. P. Lemos, S. S. Rios, M. F. Abreu, C. Kmetzsch, A. F. Sperb, L. W. Riley, M. L. Rossetti, and A. Zaha. 2008. Epidemiology of meningococcal disease in southern Brazil from 1995 to 2003, and molecular characterization of Neisseria meningitidis using multilocus sequence typing. Trop. Med. Int. Health 13:31-40. - PubMed
-
- Brehony, C., K. A. Jolley, and M. C. Maiden. 2007. Multilocus sequence typing for global surveillance of meningococcal disease. FEMS Microbiol. Rev. 31:15-26. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical